Transnational Drug Trafficking Act of 2015

Bill: 114-s-32
Sponsor: full_name: Sen. Feinstein, Dianne [D-CA]
Introduced: 2015-01-06
Policy area: Crime and Law Enforcement
Subjects: Crimes against property

Drug trafficking and controlled substances

Intellectual property
Latest action: action_date: 2016-05-16
text: Became Public Law No: 114-154.

Summaries:
action_date: 2015-01-06
action_desc: Introduced in Senate
text: <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p> Amends the Controlled Substances Import and Export Act to prohibit the manufacture or distribution of a controlled substance in schedule I or II, flunitrazepam, or a listed chemical by individuals having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within 12 miles of the U.S. coast.</p> <p>Prohibits the manufacture or distribution of a listed chemical: (1) intending or knowing that it will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the substance will be unlawfully imported into the United States. </p> <p>Amends the federal criminal code to revise the prohibition against, and penalties for, intentionally trafficking in a counterfeit drug to apply to intentionally trafficking in a drug and knowingly using a counterfeit mark on or in connection with such drug.</p>

action_date: 2015-09-17
action_desc: Reported to Senate without amendment
text: <p>(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>

action_date: 2015-10-07
action_desc: Passed Senate without amendment
text: <p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>

action_date: 2016-05-10
action_desc: Passed House without amendment
text: <p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence. </p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported. </p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States. </p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>

action_date: 2016-05-16
action_desc: Public Law
text: <p>(This measure has not been amended since it was introduced. The expanded summary of the Senate reported version is repeated here.)</p> <p><b>Transnational Drug Trafficking Act of 2015</b></p> <p>(Sec. 2) This bill amends the Controlled Substances Import and Export Act to broaden the scope of persons subject to criminal prosecution for manufacturing or distributing a controlled substance in schedule I or II, a precursor chemical, or flunitrazepam for unlawful import into the United States. The Controlled Substances Act classifies drugs, substances, and chemicals used to make drugs into one of five schedules based on the drug's medical use, potential for abuse, and risk of dependence.</p> <p>Current law prohibits such manufacture or distribution by a person who knows or intends that the substance or chemical will be unlawfully imported. This bill broadens the scope to also prohibit such manufacture or distribution by a person who reasonably believes that the substance or chemical will be unlawfully imported.</p> <p>In addition, this bill prohibits the manufacture or distribution of a precursor chemical by a person who: (1) knows or intends that the chemical will be used to manufacture a controlled substance; and (2) knows, intends, or reasonably believes that the controlled substance will be unlawfully imported into the United States.</p> <p>(Sec. 3) The legislation amends the federal criminal code to replace statutory references to prohibited trafficking in a "counterfeit drug" with references to prohibited trafficking in a "drug that uses a counterfeit mark on or in connection with the drug."</p>

tv_txt: II 114th CONGRESS 1st Session S. 32 IN THE SENATE OF THE UNITED STATES January 6, 2015 Mrs. Feinstein (for herself, Mr. Udall , Mr. Blumenthal , Ms. Klobuchar , Mr. Grassley , and Ms. Heitkamp ) introduced the following bill; which was read twice and referred to the Committee on Finance January 13, 2015 Committee discharged; referred to the Committee on the Judiciary A BILL To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). .

tv_txt: II 114th CONGRESS 1st Session S. 32 IN THE SENATE OF THE UNITED STATES January 6, 2015 Mrs. Feinstein (for herself, Mr. Udall , Mr. Blumenthal , Ms. Klobuchar , Mr. Grassley , and Ms. Heitkamp ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). .

tv_txt: II Calendar No. 232 114th CONGRESS 1st Session S. 32 IN THE SENATE OF THE UNITED STATES January 6, 2015 Mrs. Feinstein (for herself, Mr. Udall , Mr. Blumenthal , Ms. Klobuchar , Mr. Grassley , Ms. Heitkamp , Mr. Cornyn , Mr. Schumer , Ms. Ayotte , and Mr. Coons ) introduced the following bill; which was read twice and referred to the Committee on Finance January 13, 2015 Committee discharged; referred to the Committee on the Judiciary September 17, 2015 Reported by Mr. Grassley , without amendment A BILL To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). .

September 17, 2015 Reported without amendment

tv_txt: 114th CONGRESS 1st Session S. 32 IN THE SENATE OF THE UNITED STATES AN ACT To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). .

Passed the Senate October 7, 2015. Secretary

tv_txt: IC 114th CONGRESS 1st Session S. 32 IN THE HOUSE OF REPRESENTATIVES October 8, 2015 Referred to the Committee on the Judiciary , and in addition to the Committee on Energy and Commerce , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned AN ACT To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). .

Passed the Senate October 7, 2015. Julie E. Adams, Secretary

tv_txt: One Hundred Fourteenth Congress of the United States of America 2d Session Begun and held at the City of Washington on Monday, the fourth day of January, two thousand and sixteen S. 32 IN THE SENATE OF THE UNITED STATES AN ACT To provide the Department of Justice with additional tools to target extraterritorial drug trafficking activity, and for other purposes.

1. Short title This Act may be cited as the Transnational Drug Trafficking Act of 2015 . 2. Possession, manufacture or distribution for purposes of unlawful importations Section 1009 of the Controlled Substances Import and Export Act ( 21 U.S.C. 959 ) is amended— (1) by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and (2) in subsection (a), by striking It shall and all that follows and inserting the following: “It shall be unlawful for any person to manufacture or distribute a controlled substance in schedule I or II or flunitrazepam or a listed chemical intending, knowing, or having reasonable cause to believe that such substance or chemical will be unlawfully imported into the United States or into waters within a distance of 12 miles of the coast of the United States. (b) It shall be unlawful for any person to manufacture or distribute a listed chemical— (1) intending or knowing that the listed chemical will be used to manufacture a controlled substance; and (2) intending, knowing, or having reasonable cause to believe that the controlled substance will be unlawfully imported into the United States. . 3. Trafficking in counterfeit goods or services Chapter 113 of title 18, United States Code, is amended— (1) in section 2318(b)(2), by striking section 2320(e) and inserting section 2320(f) ; and (2) in section 2320— (A) in subsection (a), by striking paragraph (4) and inserting the following: (4) traffics in a drug and knowingly uses a counterfeit mark on or in connection with such drug, ; (B) in subsection (b)(3), in the matter preceding subparagraph (A), by striking counterfeit drug and inserting drug that uses a counterfeit mark on or in connection with the drug ; and (C) in subsection (f), by striking paragraph (6) and inserting the following: (6) the term drug means a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ). .

Speaker of the House of Representatives Vice President of the United States and President of the Senate